Inventor · Davis, CA, US

Glenn E. Nedwin

12Patents
5h-index
10Co-inventors
63Inventor score

Filing activity: Feb 14, 1992 → Aug 29, 2013

Most-cited inventions

PatentTitleAreaCited byStatus
US6245334A Method of causing selective immunosuppression using HL-60-related lectins Emerging Cross-Sectional Technologies 16 Expired
US5824509A Recombinant lymphotoxin cDNA and variants Emerging Cross-Sectional Technologies 13 Expired
US5693760A Method of causing selective immunosuppression using HL-60 related lectins Emerging Cross-Sectional Technologies 9 Expired
US5587460A 14-beta-gal mammalian lectins Emerging Cross-Sectional Technologies 7 Expired
US5683688A Unglycosylated recombinant human lymphotoxin polypeptides and compositions Emerging Cross-Sectional Technologies 5 Expired
US5710257A Method of causing selective immunosuppression using HL-60-related lectins Emerging Cross-Sectional Technologies 1 Expired
US5633148A Unique lectins Chemistry; Metallurgy 0 Expired
US6406679B1 Use of HL-60-related lectins in drug delivery and detection of lectin-expressing cells Human Necessities 0 Expired
US6177543A Recombinant lymphotoxin Emerging Cross-Sectional Technologies 0 Expired
US8545907B2 Alpha-amylase blend for starch processing and method of use thereof Emerging Cross-Sectional Technologies 0 Active
US8815560B2 Alpha-amylase blend for starch processing and method of use thereof Emerging Cross-Sectional Technologies 0 Active
US6153195A Method of delivering drugs to cells specific for an HL-60 lectin Emerging Cross-Sectional Technologies 0 Expired

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.